Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Schrödinger, Inc. develops physics-based computational software for drug discovery and materials science. Its platform accelerates molecule design, prediction, and optimization, serving biopharmaceutical, industrial, and academic markets worldwide. The company collaborates with leading pharma firms, licensing its solutions and advancing proprietary drug programs. Its competitive edge lies in high-accuracy simulations, large-scale molecule evaluation, and a broad pipeline of collaborative and internal therapeutics.
This description was generated via AI from an annual report. Updated about 1 year ago.